Overview

Update
Status
Acquired by on May 16, 2016
IPO / Stock
Went Public on Nov 9, 2007 / NASDAQ:NSPH
Headquarters:
Northbrook, Illinois
Description:
Nanosphere develops a molecular diagnostics platform for genomic and protein testing and analysis.
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.nanosphere.us
Social:

Company Details

Update
Founded:
1999
Contact:
8474009199
Employees:
51 - 100 | 3 in Crunchbase

Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company's instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.

Funding Rounds (3) - $39.27M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2015$4.07M / Post Ipo Debt0
Sep, 2013$30.2M / Post Ipo Equity0
Jan, 2003$5M / Series C3

Current Team (3)

Update
  • Chief Strategy Officer
  • President and Chief Executive Officer & Board of Directors
  • Vice President of Finance, Treasurer and Chief Financial Officer

Offices/Locations (1)

Update
  • HQ

    4088 Commercial Avenue

    Northbrook, Illinois 60062

    United States

Past Team (4)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos